Non-oncologic incidental uptake on FAPI PET/CT imaging.


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
Feb 2023
Historique:
pmc-release: 01 02 2024
pubmed: 2 7 2022
medline: 27 1 2023
entrez: 1 7 2022
Statut: ppublish

Résumé

Fibroblast-activation protein (FAP) is a serine protease classified in the dipeptidyl peptidase 4 (DPP4) family. FAP is predominantly expressed in activated fibroblasts such as the cancer-associated fibroblasts (CAFs). FAP expression in CAFs is associated with tumor progression and poor prognosis in solid cancers. Recently, radiolabeled FAP inhibitors (FAPI) has been developed, which enables positron emission tomography (PET) imaging of FAP. FAPI PET/CT can provide a higher tumor-to-background ratio (TBR) than

Identifiants

pubmed: 35776566
doi: 10.1259/bjr.20220463
pmc: PMC9975522
doi:

Substances chimiques

Gallium Radioisotopes 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

20220463

Références

J Nucl Cardiol. 2021 Jun;28(3):812-821
pubmed: 32975729
J Nucl Cardiol. 2022 Jun;29(3):1475-1477
pubmed: 33106984
Radiology. 2021 Feb;298(2):393-402
pubmed: 33258746
Clin Nucl Med. 2022 Jul 1;47(7):638-639
pubmed: 35426847
Ann Rheum Dis. 2020 Nov;79(11):1485-1491
pubmed: 32719042
J Nucl Med. 2020 Feb;61(2):163-165
pubmed: 31924719
Mol Imaging Biol. 2022 Apr;24(2):309-320
pubmed: 34816283
Radiology. 2022 Apr;303(1):51
pubmed: 34931860
Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1322-1337
pubmed: 34651226
Radiother Oncol. 2021 May;158:55-61
pubmed: 33621587
Clin Nucl Med. 2022 Feb 1;47(2):161-163
pubmed: 34269727
Clin Nucl Med. 2022 Jan 1;47(1):e9-e10
pubmed: 34507335
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2635-2641
pubmed: 33452634
Molecules. 2015 Jan 27;20(2):2081-99
pubmed: 25633335
Eur Heart J. 2020 Mar 1;41(9):1060
pubmed: 31630152
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3736-3737
pubmed: 33914106
J Nucl Med. 2022 Jul;63(7):1021-1026
pubmed: 34740953
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3493-3501
pubmed: 33829416
Clin Nucl Med. 2020 Dec;45(12):1020-1022
pubmed: 33086274
Clin Nucl Med. 2022 Apr 1;47(4):348-349
pubmed: 35020664
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1593-1603
pubmed: 33097975
J Nucl Cardiol. 2022 Apr;29(2):881-884
pubmed: 32803676
Clin Nucl Med. 2021 Oct 1;46(10):847-849
pubmed: 34028415
Clin Nucl Med. 2022 Mar 1;47(3):243-245
pubmed: 34406184
Clin Nucl Med. 2021 May 1;46(5):431-432
pubmed: 33782307
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2569-2580
pubmed: 31388723
Clin Nucl Med. 2022 May 1;47(5):449-450
pubmed: 35020660
Radiology. 2022 Apr;303(1):191-199
pubmed: 34981976
Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):963-979
pubmed: 34410435
Clin Nucl Med. 2022 Jun 1;47(6):545-546
pubmed: 35175940
J Nucl Med. 2022 Jan;63(1):127-133
pubmed: 34272325
Circ Cardiovasc Imaging. 2020 Sep;13(9):e010628
pubmed: 32912030
Radiology. 2022 Apr;303(1):200-201
pubmed: 34981981
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4377-4385
pubmed: 34137945
Rheumatology (Oxford). 2022 Jul 6;61(7):2999-3009
pubmed: 34450633
Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):1088-1089
pubmed: 34546387
Ann Nucl Med. 2021 Dec;35(12):1312-1320
pubmed: 34424505
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2059-2061
pubmed: 33543324
Clin Nucl Med. 2021 Dec 1;46(12):1022-1023
pubmed: 34172601
Clin Nucl Med. 2022 May 1;47(5):430-432
pubmed: 35020663
Front Oncol. 2021 Mar 11;11:651005
pubmed: 33777814
Clin Nucl Med. 2021 Nov 1;46(11):938-939
pubmed: 34028423
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):415-416
pubmed: 34401929
J Nucl Med. 2021 Jun 1;62(6):779-786
pubmed: 33097632
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):4089-4100
pubmed: 34050777
Clin Nucl Med. 2020 Oct;45(10):e430-e432
pubmed: 32332301
Endocrine. 2021 Jul;73(1):230-231
pubmed: 33860881
Clin Nucl Med. 2021 Nov 1;46(11):940-942
pubmed: 34034326
J Nucl Med. 2021 Feb;62(2):266-271
pubmed: 32513902
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):73-86
pubmed: 32588089
Thyroid. 2022 Jan;32(1):65-77
pubmed: 34641705
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1604-1617
pubmed: 33179149
Clin Nucl Med. 2021 May 1;46(5):419-421
pubmed: 33630803
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):709-720
pubmed: 34241652
Clin Nucl Med. 2021 Feb 1;46(2):e86-e87
pubmed: 32701818
Eur Heart J. 2011 Nov;32(21):2713-22
pubmed: 21292680
Front Med (Lausanne). 2021 Nov 23;8:782231
pubmed: 34888332
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1682-1683
pubmed: 33247327
Clin Nucl Med. 2021 Mar 1;46(3):e141-e150
pubmed: 33351507
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
Clin Nucl Med. 2021 Oct 1;46(10):840-841
pubmed: 34172606
Clin Nucl Med. 2021 Aug 1;46(8):e433-e435
pubmed: 33782295
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):196-203
pubmed: 32468254
J Nucl Med. 2022 Jun;63(6):890-896
pubmed: 34620730
Radiology. 2022 Jan;302(1):39-47
pubmed: 34636633
J Nucl Med. 2022 Sep;63(9):1415-1423
pubmed: 35210301
AJR Am J Roentgenol. 2021 Feb;216(2):305-306
pubmed: 32755205
Ann Nucl Med. 2021 Dec;35(12):1321-1331
pubmed: 34436740
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):924-926
pubmed: 32651662
Cancer Metastasis Rev. 2020 Sep;39(3):783-803
pubmed: 32601975
J Nucl Med. 2019 Mar;60(3):386-392
pubmed: 30072500
Clin Nucl Med. 2022 Mar 1;47(3):223-225
pubmed: 34392279
Clin Nucl Med. 2021 Aug 1;46(8):683-685
pubmed: 33826569
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2051-2052
pubmed: 33462628
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2786-2797
pubmed: 34984503
Clin Nucl Med. 2021 Aug 1;46(8):694-696
pubmed: 33826568
Clin Nucl Med. 2020 Apr;45(4):310-311
pubmed: 31977474
Eur Heart J Cardiovasc Imaging. 2022 Feb 22;23(3):e123
pubmed: 34643688
Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2078-2079
pubmed: 32385646
Clin Nucl Med. 2022 Jun 1;47(6):564-565
pubmed: 35081060
Clin Nucl Med. 2022 May 1;47(5):469-470
pubmed: 35025803
Nucl Med Mol Imaging. 2021 Aug;55(4):194-198
pubmed: 34422130
Mol Oncol. 2016 Jan;10(1):40-58
pubmed: 26304112
Clin Nucl Med. 2022 Mar 1;47(3):e306-e310
pubmed: 35025794
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):651-652
pubmed: 32643006
Eur Heart J Case Rep. 2022 Jan 09;6(1):ytac005
pubmed: 35079689
Br J Radiol. 2018 Apr;91(1084):20170774
pubmed: 29243502
Contrast Media Mol Imaging. 2021 Nov 23;2021:9750080
pubmed: 34887714
Clin Nucl Med. 2021 May 1;46(5):427-430
pubmed: 33661204
J Nucl Med. 2021 Mar;62(3):296-302
pubmed: 33277397
PLoS One. 2015 Mar 16;10(3):e0116683
pubmed: 25775399

Auteurs

Masatoshi Hotta (M)

Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California, Los Angeles, USA.

Angela C Rieger (AC)

Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California, Los Angeles, USA.

Mahbod G Jafarvand (MG)

Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California, Los Angeles, USA.

Nandakumar Menon (N)

Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California, Los Angeles, USA.

Andrea Farolfi (A)

Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California, Los Angeles, USA.

Matthias R Benz (MR)

Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California, Los Angeles, USA.
Department of Radiological Sciences, University of California Los Angeles, Los Angeles, CA, United States.

Jeremie Calais (J)

Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California, Los Angeles, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH